Muzaffar Akram

1.9k citations
22 papers · 1.1k indexed · h-index 15
Topics
Breast Cancer Treatment Studies (7 papers)Breast Lesions and Carcinomas (7 papers)Cancer Genomics and Diagnostics (5 papers)

In The Last Decade

Muzaffar Akram

21 papers receiving 1.1k citations

Peers

Muzaffar Akram
Comparison fields: 5 of 65
  • Oncology 483
  • Cancer Research 442
  • Pathology and Forensic Medicine 407
  • Molecular Biology 317
  • Pulmonary and Respiratory Medicine 235
Replace Yves Denoux with:
Yves Denoux France
J. S. Reis-Filho United Kingdom
Felipe C. Geyer United Kingdom
Bradley Wubbenhorst United States
Yasuyo Ohi Japan
Fresia Pareja United States
Ronggang Lang China
Tuula Kuukasjärvi Finland
Daniel Wai United States
WJ Gullick United Kingdom
Muzaffar Akram relative to Yves Denoux France Yves Denoux's profile →
Citations per field
00.5×3.2×
Yves Denoux · 1×
Citations per year

Countries citing papers authored by Muzaffar Akram

Since Specialization
Citations

This map shows the geographic impact of Muzaffar Akram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffar Akram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffar Akram more than expected).

Fields of papers citing papers by Muzaffar Akram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffar Akram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffar Akram. The network helps show where Muzaffar Akram may publish in the future.

Co-authorship network of co-authors of Muzaffar Akram

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffar Akram. A scholar is included among the top collaborators of Muzaffar Akram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffar Akram. Muzaffar Akram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 186
3 85
4 29
5 10
6 64
7 2
8 77
9 53
10 43
11 92
12 28
13 4
14 33
15 65
16 127
17 102
18 6
19 10
20 0

About Muzaffar Akram

Muzaffar Akram is a scholar working on Cancer Research, Pathology and Forensic Medicine and Dermatology, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (442 citations), Dermatology (218 citations) and Pathology and Forensic Medicine (407 citations). Muzaffar Akram has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Edi Brogi, Larry Norton, Lee K. Tan, Melissa P. Murray, Britta Weigelt, Jorge S. Reis‐Filho, William L. Gerald, Philip B. Paty, Jinru Shia and Laura Liberman. Their work appears in journals such as Cell, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026